申请人:CoMentis, Inc.
公开号:US20160009706A1
公开(公告)日:2016-01-14
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.
提供了替代性的喹诺啡啶化合物,包括这些化合物的药物组合物,以及使用这些化合物调节α7烟碱乙酰胆碱受体和治疗神经系统疾病的方法。